CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Executive Officer gave up 779 shares (to pay taxes)
- 4 Open-market sale CBO & COO sold 100,000 shares at an average $128.05 ($12,805,240)
- 4 Open-market sale Director sold 30,374 shares at an average $132.37 ($4,020,667)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,352 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 5,526 shares (to pay taxes)
- 4 Shares withheld for taxes CBO & COO gave up 2,141 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel and Secretary gave up 1,353 shares (to pay taxes)
- 4 Shares withheld for taxes Executive VP, Head of R&D gave up 2,141 shares (to pay taxes)
- 4/A Exercise or conversion CBO & COO acquired 16,334 shares (option exercise)
- 4 Shares withheld for taxes Executive VP, Head of R&D gave up 1,585 shares (to pay taxes)
- 4 Other disposition Director disposed of 338,165 shares (other)
- 4 Shares withheld for taxes Chief Executive Officer gave up 798 shares (to pay taxes)
Page 12 of 26 · 502 filings